Ecstasy use and self-reported disturbances in sleep

Human Psychopharmacology

Volumn 26, Issue 7, 2011, Pages 508-516

  Ogeil, Rowan P ^a   Rajaratnam, Shantha M W ^a   Phillips, James G ^a   Redman, Jennifer R ^a   Broadbear, Jillian H ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

ecstasy; polydrug use; sleep disturbance; sleep quality

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE;

ADULT; ARTICLE; DRUG USE; EPWORTH SLEEPINESS SCALE; FEMALE; HUMAN; MALE; MULTIPLE DRUG ABUSE; PITTSBURGH SLEEP QUALITY INDEX; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SELF REPORT; SLEEP DISORDER; SLEEP QUALITY;

ADOLESCENT; ADULT; AGE FACTORS; FEMALE; HALLUCINOGENS; HUMANS; MALE; MIDDLE AGED; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; QUESTIONNAIRES; RISK FACTORS; SLEEP; SLEEP DISORDERS; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 80755133580     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.1233     Document Type: Article

References (40)

1. Allen RP, McCann UD, Ricaurte GA,. 1993. Persistent effects of (+/-)3,4-methylenedioxymethamphetamine (MDMA, " ecstasy") on human sleep. Sleep 16: 560-564. (Pubitemid 23286946)
2. Allott K, Redman J,. 2006. Patterns of use and harm reduction practices of ecstasy users in Australia. Drug Alcohol Depend 82: 168-176.
3. Bedi G, Redman J,. 2006. Self-reported ecstasy use: the impact of assessment method on dosage estimates in recreational users. J Psychopharmacol 20: 432-436.
4. Benbadis SR, Mascha E, Perry MC, Wolgamuth BR, Smolley LA, Dinner DS,. 1999. Association between the Epworth Sleepiness Scale and the Multiple Sleep Latency Test in a clinical population. Ann Intern Med 130: 289-292. (Pubitemid 29091857)
5. Buysse DJ, Reynolds ICF, Monk TH, Berman SR, Kupfer DJ,. 1989. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res 28: 193-213. (Pubitemid 19144991)
6. Carhart-Harris RL, Nutt DJ, Munafo M, Christmas DM, Wilson SJ,. 2009a. Equivalent effects of acute tryptophan depletion on REM sleep in ecstasy users and controls. Psychopharmacology 206: 187-196.
7. Carhart-Harris RL, Nutt DJ, Munafo M, Wilson SJ,. 2009b. Current and former ecstasy users report different sleep to matched controls: a web-based questionnaire study. J Psychopharmacol 23: 249-257.
8. Cottler LB, Leung KS, Abdallah AB,. 2009. Test-re-test reliability of DSM-IV adopted criteria for 3,4-methylenedioxymethamphetamine (MDMA) abuse and dependence: a cross-national study. Addiction 104: 1679-1690.
9. Degenhardt L, Roxburgh A, Dunn M, Campbell G, Bruno R, Kinner SA, et al,. 2009. The epidemiology of ecstasy use and harms in Australia. Neuropsychobiology 60: 176-187.
10. Drake C, Roehrs T, Roth T,. 2003. Insomnia causes, consequences, and therapeutics: an overview. Depress Anxiety 18: 163-176. (Pubitemid 38056063)
11. Engels RCME, ter Bogt TFM,. 2004. Outcome expectancies and ecstasy use in visitors of rave parties in the Netherlands. Eur Addict Res 10: 156-162. (Pubitemid 40069606)
12. Gosling SD, Vazire S, Srivastava S, John OP,. 2004. Should we trust web-based studies? A comparative analysis of six preconceptions about internet questionnaires. Am Psychol 59: 93-104. (Pubitemid 38318025)
13. Gouzoulis-Mayfrank E, Daumann J,. 2006. The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview. Psychopharmacology 20: 188-193.
14. Johns MW,. 1991. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14: 540-545.
15. Johns MW,. 1992. Reliability and factor analysis of the Epworth Sleepiness Scale. Sleep 15: 376-381.
16. Jones K, Callen F, Blagrove M, Parrott A,. 2008. Sleep, energy and self rated cognition across 7 nights following recreational ecstasy/MDMA use. Sleep Hypn 10: 26-38.
17. Liechti ME, Vollenweider FX,. 2000. The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4-methylenedioxymethamphetamine ('Ecstasy') in healthy volunteers. J Psychopharmacol 14: 269-274.
18. Lim J, Dinges DF,. 2008. Sleep deprivation and vigilant attention. Ann N Y Acad Sci 1129: 305-322. (Pubitemid 351990273)
19. Lockley SW, Barger LK, Ayas NT, Rothschild JM, Czeisler CA, Landrigan CP, et al,. 2007. Effects of health care provider work hours and sleep deprivation on safety and performance. Jt Comm J Qual Patient Saf 33: 7-18.
20. McCann UD, Peterson SC, Ricaurte GA,. 2007. The effect of catecholamine depletion by alpha-methyl-para-tyrosine on measures of cognitive performance and sleep in abstinent MDMA users. Neuropsychopharmacology 32 (8): 1695-1706. (Pubitemid 47076382)
21. Measham F, Aldridge J, Parker H,. 2001. Dancing on drugs: risks, health and hedonism in the British Club scene. Free Association Books: London.
22. Montgomery C, Fisk JE, Wareing M, Murphy P,. 2007. Self-reported sleep quality and cognitive performance in ecstasy users. Hum Psychopharmacol 22: 537-548.
23. Monti JM, Pandi-Perumal SL, Jacobs BL, Nutt DJ,. 2008. Serotonin and Sleep: Molecular, Functional and Clinical Aspects. Birkhauser Verlag: Berlin.
24. O'Regan M, Clow A,. 2004. Decreased pain tolerance and mood in recreational users of MDMA. Psychopharmacology 173: 446-451. (Pubitemid 38703821)
25. Parrott AC,. 2000. Human research on MDMA (3,4- methylenedioxymethamphetamine) neurotoxicity: cognitive and behavioural indices of change. Neuropsychobiology 42: 17-24. (Pubitemid 30436312)
26. Parrott AC, Sisk E, Turner JJD,. 2000. Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users. Drug Alcohol Depend 60: 105-110. (Pubitemid 30255991)
27. Parrott AC, Buchanan T, Scholey AB, Heffernan TM, Ling J, Rodgers J,. 2002. Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users. Hum Psychopharmacol 17: 309-312.
28. Parrott AC, Rodgers J, Buchanan T, Ling J, Heffernan TM, Scholey AB,. 2006. Dancing hot on ecstasy: physical activity and thermal comfort ratings are associated with the memory and other psychobiological problems reported by recreational MDMA users. Hum Psychopharmacol 21: 285-298. (Pubitemid 44203211)
29. Pirona A, Morgan MJ,. 2010. An investigation of the subacute effects of ecstasy on neuropsychological performance, sleep and mood in regular ecstasy users. J Psychopharm 24: 175-185.
30. Randall S, Johanson C-E, Tancer M, Roehrs T,. 2009. Effects of acute 3,4-methylenedioxymethamphetamine on sleep and daytime sleepiness in MDMA users: a preliminary study. Sleep 32: 1513-1519.
31. Reneman L, Booij J, Schmand B, van den Brink W, Gunning B,. 2000. Memory disturbances in " Ecstasy" users are correlated with an altered brain serotonin neurotransmission. Psychopharmacology 148: 322.
32. Rodgers J, Buchanan T, Scholey AB, Heffernan TM, Ling J, Parrott AC,. 2001. Differential effects of ecstasy and cannabis on self-reports of memory ability: a web-based study. Hum Psychopharmacol 16: 619-625. (Pubitemid 34036943)
33. Sangal RB, Mitler MM, Sangal JM,. 1999. Subjective sleepiness ratings (Epworth sleepiness scale) do not reflect the same parameter of sleepiness as objective sleepiness (maintenance of wakefulness test) in patients with narcolepsy. Clin Neurophysiol 110: 2131-2135. (Pubitemid 29528410)
34. Scholey AB, Owen L, Gates J, et al,. 2011. Hair MDMA samples are consistent with reported ecstasy use: findings from a study investigating effects of ecstasy on mood and memory. Neuropsychobiology 63: 15-21.
35. Shekleton JA, Rogers NL, Rajaratnam SMW,. 2010. Searching for the daytime impairments of primary insomnia. Sleep Med Rev 14: 47-60.
36. Sindicich N, Burns L, Stafford J, George F, Kong F, Matthews A, et al,. 2009. Australian trends in ecstasy and related drugs markets 2008: findings from the Ecstasy and Related Drugs Reporting System (EDRS) Australian Drug Trends Series No. 28: National Drug And Alcohol Research Centre, University of New South Wales.
37. Staner L,. 2010. Comorbidity of insomnia and depression. Sleep Med Rev 14: 35-46.
38. Topp L, Hando J, Dillon P, Roche A, Solowij N,. 1999. Ecstasy use in Australia: patterns of use and associated harm. Drug Alcohol Depend 55: 105-115. (Pubitemid 29222009)
39. Weaver T,. 2001. Outcome measurement in sleep medicine practice and research: Part 1: assessment of symptoms, subjective and objective daytime sleepiness, health-related quality of life and functional status. Sleep Med Rev 5: 103-128. (Pubitemid 32666488)
40. Wirz-Justice A, Van den Hoofdakker RH,. 1999. Sleep deprivation in depression: what do we know, where do we go? Biol Psychiatry 46: 445-453. (Pubitemid 29369070)